EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Gino Gerosa
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tarantini, G.
Right arrow Articles by Iliceto, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tarantini, G.
Right arrow Articles by Iliceto, S.
Related Collections
Right arrow Valve disease

Eur J Cardiothorac Surg 2003;24:879-885
© 2003 Elsevier Science NL


Aortic valve replacement in severe aortic stenosis with left ventricular dysfunction: determinants of cardiac mortality and ventricular function recovery

Giuseppe Tarantini*, Paolo Buja, Roldano Scognamiglio, Renato Razzolini, Gino Gerosa, Giambattista Isabella, Angelo Ramondo, Sabino Iliceto

Department of Cardiology and Cardio-thoracic Surgery, Policlinico Universitario, University of Padua, Via Giustiniani 2, 35128 Padua, Italy

Received 3 July 2003; received in revised form 20 August 2003; accepted 26 August 2003.

* Corresponding author. Tel.: +39-049-8212310; fax: +39-049-8761764
e-mail: giuseppe.tarantini.1{at}unipd.it

Objective: The influence of left ventricular (LV) dysfunction on survival of patients with severe aortic stenosis is poorly characterized. Few data are available about preoperative predictors of cardiac mortality and LV function recovery after aortic valve replacement of such patients. The aim of our study was to examine the outcome and the preoperative predictors of postoperative cardiac death and of LV function recovery in these patients. Methods: We evaluated 85 consecutive patients with severe aortic stenosis (aortic valve area <1 cm2) and severe depression of LV ejection fraction (EF) <35% at cardiac catheterization. Among them, 52 underwent aortic valve replacement and they were compared to patients who were not operated on. All patients had a mean clinical follow-up of 53 months and 94% of them had a mean echocardiographic follow-up of 14 months after aortic valve replacement. Results: The mean baseline characteristics included: LVEF 28±6%, peak-to-peak transvalvular gradient 51±29 mmHg, aortic valve area 0.63±0.25 cm2. Thirty-three patients did not undergo aortic valve replacement: 32 of them died within 3 years. Fifty-two patients underwent aortic valve replacement and 16 had a concomitant coronary bypass surgery. In-hospital mortality was 8%. Postoperative NYHA functional class changed from 2.84±0.67 to 1.43±0.44 (P<0.001) and LVEF from 29±6% to 43±10% (P<0.001). At follow-up 10 patients died of heart disease. By multivariate analysis, preoperative LV end-systolic volume index (ESVI) was the only covariate of cardiac death (LVESVI/10 ml/m2, OR 1.3, CI 1.1–1.8, P<0.028). By using a receiver operating characteristic curve, LVESVI<=90 ml/m2 was the best cut-off value (sensitivity and specificity 78%) to fit with a better survival (93% vs. 63%, P<0.01) and with LVEF recovery after aortic valve replacement (EF improved by 15±10% vs. 8±5%, P<0.001). Conclusions: Despite LV dysfunction, aortic valve replacement appears to change drastically the natural history of severe aortic stenosis. Preoperative LV levels predict different postoperative survival rate and LVEF recovery.

Key Words: Aortic stenosis • Surgery • Survival • Ventricular function




This article has been cited by other articles:


Home page
HeartHome page
J Bermejo and R Yotti
Low-gradient aortic valve stenosis: value and limitations of dobutamine stress testing
Heart, March 1, 2007; 93(3): 298 - 302.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Cribier, H. Eltchaninoff, C. Tron, F. Bauer, C. Agatiello, D. Nercolini, S. Tapiero, P.-Y. Litzler, J.-P. Bessou, and V. Babaliaros
Treatment of Calcific Aortic Stenosis With the Percutaneous Heart Valve: Mid-Term Follow-Up From the Initial Feasibility Studies: The French Experience
J. Am. Coll. Cardiol., March 21, 2006; 47(6): 1214 - 1223.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Chukwuemeka, V. Rao, S. Armstrong, J. Ivanov, and T. David
Aortic valve replacement: a safe and durable option in patients with impaired left ventricular systolic function
Eur. J. Cardiothorac. Surg., February 1, 2006; 29(2): 133 - 138.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
H Baumgartner
What influences the outcome of valve replacement in critical aortic stenosis?
Heart, October 1, 2005; 91(10): 1254 - 1256.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
R. G. Fuster, J. A. Montero Argudo, O. G. Albarova, F. Hornero Sos, S. Canovas Lopez, M. Bueno Codoner, J. A. Buendia Minano, and I. Rodriguez Albarran
Left ventricular mass index as a prognostic factor in patients with severe aortic stenosis and ventricular dysfunction
Interactive CardioVascular and Thoracic Surgery, June 1, 2005; 4(3): 260 - 266.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2003 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.